Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial

Chunde Bao, Chen Shunle, GU Yueying, Lao Zhiying, Ni Liqing, Qiang Yu, Jianhua Xu, Xianpei Li, Jialing Liu, Lingyun Sun, Piegen He, Jilang Ma, Shuyun Xu, Changhai Ding

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)
Original languageEnglish
Pages (from-to)1228 - 1234
Number of pages7
JournalChinese Medical Sciences Journal
Volume116
Issue number8
Publication statusPublished - 2003

Cite this